🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lisa A. Kachnic

NewYork–Presbyterian Hospital

ORCID: 0000-0001-8239-9147

Also affiliated with Columbia University Irving Medical Center, Columbia University

MedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.870Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors

Gynecologic Oncology(2023)10.1016/j.ygyno.2022.12.017

Top 23%

0.870DataRank

Top 23%21 citations

Tracy E. Crane, Austin Miller, Michael A. Gold, Matthew A. Powell, Kristin Bixel +15 more

Papers

Driven by 14 papers — median percentile 77. Top paper: “Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors”.

Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors

Gynecologic Oncology(2023)10.1016/j.ygyno.2022.12.017

Top 23%

0.870DataRank

Top 23%21 citations

Tracy E. Crane, Austin Miller, Michael A. Gold, Matthew A. Powell, Kristin Bixel +15 more

Current treatment and future directions in the management of anal cancer

CA A Cancer Journal for Clinicians(2021)10.3322/caac.21712

N/A

0DataRank · unranked

27 citations

Cathy Eng, Craig Messick, Theodore S. Hong, Ethan B. Ludmir, Lisa A. Kachnic +2 more

NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC)—Pembrolizumab experimental arm (EA) primary results.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.8

N/A

0DataRank · unranked

32 citations

Greg Yothers, Theodore S. Hong, Marcia M. Russell, Y. Nancy You, William Parker +10 more

A Multimedia Strategy to Integrate Introductory Broad-Based Radiation Science Education in US Medical Schools

Journal of the American College of Radiology(2022)10.1016/j.jacr.2022.08.010

N/A

0DataRank · unranked

7 citations

Kimberly E. Applegate, Cynthia H. McCollough, Janet E. Bailey, Cedric M. Bright, Jerrold T. Bushberg +21 more

NRG-CC008: A nonrandomized prospective clinical trial comparing the non-inferiority of salpingectomy to salpingo-oophorectomy to reduce the risk of ovarian cancer among BRCA1 carriers [SOROCk].

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps10615

N/A

0DataRank · unranked

13 citations

Stephanie L. Pugh, Joan L. Walker, Kathryn P. Pennington, Elizabeth L. Jewell, Laura J. Havrilesky +7 more

Five- or 10-year colonoscopy for 1-2 non-advanced adenomatous polyps (FORTE) NRG-CC005 study: A randomized phase III non-inferiority trial comparing colorectal cancer incidence in participants with 1-2 non-advanced adenomas randomized to a 5- and 10-year surveillance colonoscopy exam schedule versus a 10-year surveillance colonoscopy exam schedule.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps3631

N/A

0DataRank · unranked

1 citations

Hanna Bandos, Douglas Corley, Jeff Dueker, Greg Yothers, Jinbing Bai +6 more

Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809)

Annals of Surgical Oncology(2023)10.1245/s10434-022-12863-9

N/A

0DataRank · unranked

13 citations

Sarah Colby, David P. Horowitz, Katherine A. Guthrie, Edgar Ben‐Josef, Anthony B. El-Khoueiry +6 more

NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad143

N/A

0DataRank · unranked

2 citations

Rebecca C. Auer, May Cho, N.A. Dasari, Cynthia Davies-Venn, Cathy Eng +36 more

NRG/RTOG 1112: Randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.489

N/A

0DataRank · unranked

60 citations

Kathryn Winter, Jennifer J. Knox, Andrew X. Zhu, Sunil Krishnan, Chandan Guha +15 more

Long-term results from NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.7

N/A

0DataRank · unranked

40 citations

Greg Yothers, Osama E. Rahma, Theodore S. Hong, Marcia M. Russell, Y. Nancy You +14 more

Patient-reported outcomes during pelvic radiation therapy: A secondary analysis on sexual function from NRG-RTOG 1203.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5533

N/A

0DataRank · unranked

1 citations

Rebecca Paulus, Ann H. Klopp, Lari Wenzel, Anamaria R. Yeung, J. S. Thompson +15 more

Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus

Practical Radiation Oncology(2024)10.1016/j.prro.2023.08.016

N/A

0DataRank · unranked

18 citations

Joel E. Tepper, Andrew M. Moon, Aisling Barry, Meritxell Mollà, Jinsil Seong +33 more

Trastuzumab with trimodality treatment for esophageal adenocarcinoma with HER2 overexpression: NRG Oncology/RTOG 1010.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4500

N/A

0DataRank · unranked

36 citations

Kathryn Winter, Dennis A. Wigle, Thomas A. DiPetrillo, Michael G. Haddock, Theodore S. Hong +15 more

Chemotherapy dose density is prognostic for overall survival in patients with resectable pancreas cancer: A landmark analysis of SWOG 1505

Cancer(2025)10.1002/cncr.35759

N/A

0DataRank · unranked

2 citations

Sarah Colby, Davendra Sohal, Katherine A. Guthrie, Lisa A. Kachnic, E. Gabriela Chiorean +6 more